Skip to main content
. 2013 Jan 23;8(1):e54191. doi: 10.1371/journal.pone.0054191

Figure 3. sCD44 (A) and sVCAM-1 (B) concentrations in the vitreous fluid of patients with secondary ERM and proliferative vitreoretinopathy patients (PVR-ERM).

Figure 3

The levels of both sCD44 and sVCAM-1 were significantly higher in the patients with PVR than in the eyes with secondary ERM (*P<0.001).